Rheumatoid arthritis drug may take on some aggressive cancers

Some cancer patients with aggressive tumours may benefit from a class of anti-inflammatory drugs (JAK inhibitors) used to treat rheumatoid arthritis, suggests a study published in Cell Reports.
“There are JAK inhibitors in use for rheumatoid arthritis and being tested against a number of other conditions,” Weber said. “Our data suggest that these anti-inflammatory drugs may be a way to treat some patients missing both p53 and ARF [proteins that are encoded by genes known for being highly mutated in various cancers].”
To read the original research click here.